INS and glaucoma: While we acknowledge the limitation of not measuring systemic metabolic parameters (glucose, insulin, HOMA-IR) in our non-diabetic cohort, our findings align with the hypothesis of metabolic dysfunction in glaucoma proposed by Faiq et al. [27] and highlight the potential of these metabolic markers as biomarkers for metabolic stress in glaucomatous eyes.